secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOROX CO /DE/ (CLX)
CIK:        0000021076
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0000021076-23-000013
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clorox Q3 FY2023: adj EPS +15%, net sales +6%, raises full-year outlook
-----------------------------------------------------------------------

- Net sales $1.91B (+6% YoY); organic sales +8%; gross margin 41.8% (+590 bps).
- Adjusted EPS $1.51 (+15% YoY); GAAP diluted EPS loss $1.71 due to $445M impairment in vitamins.
- YTD operating cash flow $728M, up 61% YoY; free cash flow $584M, 10.9% of sales.
- Health & Wellness segment volume -16% but price/mix +23%; Lifestyle sales +15%.
- Company raises FY2023 outlook citing pricing, cost savings, and strategic investments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21076/000002107623000013/0000021076-23-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21076/000002107623000013/clx-20230502.htm
  HTML page:      https://secwatch.observer/filing/0000021076-23-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer